To date, Meinox has been funded by management and incubation centers. In addition, we have received a number of governmental grants and innovation awards in the support of drug development.
Meinox is always searching for possibilities that could support the company and the product pipeline. For any inquiries regarding investments please contact CEO of Meinox at firstname.lastname@example.org.
To fully exploit the potential of our drug candidates, we welcome strategic partnerships with renowned biotech and pharmaceutical companies. If you share our vision to develop and commercialize the next generation of personalized oncology therapies, please contact us to find out more about partnering opportunities with Meinox.
We are always looking to develop our team.
Meinox is looking for motivated and experienced professionals in drug development. In the coming years, we will take MEIS inhibitors to preclinical development stage and to the clinic trials. If you want to be part of this endeavor, write us below.
We need expertise in process and analytical development, product manufacturing, quality control, proof-of-concept, preclinical efficacy and safety studies, in vitro and in vivo models, GMP and IND process.
Web sitesi trafiğini analiz etmek ve web sitesi deneyiminizi optimize etmek amacıyla çerezler kullanıyoruz. Çerez kullanımımızı kabul ettiğinizde, verileriniz tüm diğer kullanıcı verileriyle birlikte derlenir.